White matter lesions are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetes mellitus patients

Metabolism: Clinical and Experimental

Volumn 58, Issue 5, 2009, Pages 696-703

  Anan, Futoshi ^a,b   Masaki, Takayuki ^b   Shinohara, Tetsuji ^b   Yufu, Kunio ^b   Takahashi, Naohiko ^b   Nakagawa, Mikiko ^b   Eshima, Nobuoki ^c   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^b  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; NORADRENALIN;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMALE; HEART RATE VARIABILITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SCINTIGRAPHY; WHITE MATTER;

3-IODOBENZYLGUANIDINE; AGED; BAROREFLEX; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NOREPINEPHRINE; PILOT PROJECTS; RADIOPHARMACEUTICALS;

EID: 64349103380     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.01.012     Document Type: Article

References (41)

1. Pantoni L., and Garcia J.H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke 26 (1995) 1293-1301
2. Wong T.Y., Klein R., and Sharrett A.R. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288 (2002) 67-74
3. Vermeer S.E., Hollander M., van Dijk E.J., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34 (2003) 1126-1129
4. Tsuji H., Larson M.G., Venditti Jr. F.J., et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Study. Circulation 94 (1996) 2850-2855
5. La Rovere M.T., Bigger Jr. J.T., and Marcus F.I. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction Investigators. Lancet 351 (1998) 478-484
6. Takahashi N., Anan F., Nakagawa M., et al. Microalbuminuria, cardiovascular autonomic function, and insulin resistance in patients with type 2 diabetic patients. Metabolism 53 (2004) 1359-1364
7. 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 34 (2007) 28-35
8. 123I-metaiodobenzylguanidine scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 34 (2007) 1189-1197
9. Schmidt R., Launer L.J., and Nilsson L.G. CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53 (2004) 687-692
10. Jongen C., van der Grond J., and Kappelle L.J. Utrecht Diabetic Encephalopathy Study Group. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 50 (2007) 1509-1516
11. Gerritsen J., TenVoorde B.J., Dekker J.M., et al. Measures of cardiovascular autonomic dysfunction nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects. Diabetologia 46 (2003) 330-338
12. 123I-MIBG. J Nucl Med 40 (1999) 6-11
13. Spallone V., and Menzinger G. Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 46 (1997) S67-S76
14. Watanabe K., Sekiya M., and Tsuruoka T. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens 17 (1999) 1161-1168
15. Mancia G., De Backer G., Dominiczak A., et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25 (2007) 1751-1762
16. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
17. Liao D., Sloan R.P., Cascio W.E., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 21 (1998) 2116-2122
18. Breteler M.M., van Swieten J.C., Bots M.L., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44 (1994) 1246-1252
19. Rakowski H., Appleton C., Chan K.L., et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 9 (1996) 736-760
20. Sato T., Nishinaga M., Kawamoto A., et al. Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 21 (1993) 866-874
21. Anan F., Takahashi N., Nakagawa M., et al. High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism 54 (2005) 552-558
22. Pedlhauzer E.J. Multiple regression in behavior research: explanation and prediction. 3rd ed. (1997), Harcourt Brace, Fort Worth (Tex)
23. Shimada K., kawamoto A., and Matsubayashi K. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 16 (1990) 692-699
24. Sierra C., de la Sierra A., and Mercader J. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 20 (2002) 519-524
25. Steinberg H.O., Chaker H., and Leaming R. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
26. Hu C.T., Chang K.C., Wu C.Y., et al. Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat. Br J Pharm 122 (1997) 1237-1243
27. Indolfi C., Torella D., and Cavuto L. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103 (2001) 2980-2986
28. Tokgozoglu S.L., Batur M.K., Top uoglu M.A., et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 30 (1999) 1307-1311
29. Robinson T.G., Dawson S.L., Eames P.J., et al. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 34 (2003) 705-712
30. Rufa A., Guideri F., Acampa M., et al. Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke 38 (2007) 276-280
31. Kinjyo Y., Kajiyama S., Fujiwara H., et al. Influence of the polyol pathway on transporter reduction in diabetic cardiac sympathetic nerve: implication for heterogeneous accumulation of MIBG. Eur J Nucl Med Imaging 32 (2005) 438-442
32. Glowniak J.V., Kilty J.E., Amara S.G., et al. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med. 34 (1993) 1140-1146
33. 123I] metaiodobenzylguanidine. Diabetes 41 (1992) 1069-1075
34. Shimomura T., Anan F., and Umeno Y. Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Neurol 15 (2008) 289-294
35. Anan F., Masaki T., and Iwao T. The role of microalbuminuria and insulin resistance as significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Curr Med Res Opin 24 (2008) 1561-1567
36. Ghiadoni L., Donald A.E., and Cropley M. Mental stress induces transient endothelial dysfunction in humans. Circulation 102 (2000) 2473-2478
37. Hijmering M.L., Stroes E.S., and Olijhoek J. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilatation. J Am Coll Cardiol 39 (2002) 683-688
38. Gavras H.P. Issues in hypertension: drug tolerability and special populations. Am J Hypertens 14 Pt 2 (2001) 231S-236S
39. Lender D., Arauz-Pacheco C., Breen L., et al. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 12 (1999) 298-303
40. Kontopoulos A.G., Athyros V.G., and Didangelos T.P. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20 (1997) 355-361
41. Rodgers J.E., and Patterson J.H. Angiotensin II-receptor blockers: clinical relevance and therapeutic role. Am J Health Syst Pharm 58 (2001) 671-683